Purdue to pay $8.3bn after admitting criminal charges in opi...

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost it up to $8.3 billion.

Orexo eyes opioid use disorder app launch before year-end

Sweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course for a launch before the end of the year in the US.

After final $600M opioid settlement, Indivior looks to the f...

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the US behind it, after agreeing a $600 million settlement.

Mallinckrodt proposes $1.6bn deal to settle opioid litigatio...

FDA rejects Adamis opioid overdose therapy Zimhi, hitting sh...

Federal opioid trial averted by last-ditch settlement